Synapse - Ira Dunkel

Search Within

Ira J Dunkel

Results (371)

Phase 1 dose-escalation trial using convection-enhanced delivery of radiolabeled monoclonal antibody for diffuse intrinsic pontine glioma following external radiation therapy

Meeting Abstract

Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J. A.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Donzelli, M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: A Pediatric Brain Tumor Consortium study

Journal Article

Fangusaro, J.; Onar-Thomas, A.; Poussaint, T. Y.; Wu, S.; Ligon, A. H.; Lindeman, N.; Campagne, O.; Banerjee, A.; Gururangan, S.; Kilburn, L. B.; more...
Neuro-Oncology (2021)

Fulltext@MSK | Save

Debio1347, an oral FGFR inhibitor: Results from a single-center study in pediatric patients with recurrent or refractory FGFR-altered gliomas

Journal Article

Sait, S. F.; Gilheeney, S. W.; Bale, T. A.; Haque, S.; Dinkin, M. J.; Vitolano, S.; Rosenblum, M. K.; Ibanez, K.; Prince, D. E.; Spatz, K. H.; more...
JCO Precision Oncology (2021)

Fulltext@MSK | Save

Successful treatment of massive choroidal invasion in retinoblastoma with intra-arterial chemotherapy (ophthalmic artery chemosurgery)

Research Letter

Abramson, D. H.; Gobin, Y. P.; Dunkel, I. J.; Francis, J. H.
Ophthalmology Retina (2021)

Fulltext@MSK | Save

Debio1347, an oral FGFR inhibitor: Results from a single center study in recurrent/refractory FGFR altered pediatric glioma

Meeting Abstract

Sait, S. F.; Gilheeney, S.; Bale, T.; Rosenblum, M.; Haque, S.; Ibanez, K.; Dinkin, M.; Vitolano, S.; Dunkel, I.; Karajannis, M.
Neuro-Oncology (2021)

Fulltext@MSK | Save

Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in adolescent and young adult (AYA) brain tumor patients

Meeting Abstract

Miller, A.; Szalontay, L.; Bouvier, N.; Ahmed, H.; Hill, K.; Rafailov, J.; Lee, A.; Rodriguez-Sanchez, I.; Yildirim, O.; Patel, A.; more...
Neuro-Oncology (2021)

Fulltext@MSK | Save

A phase I and surgical study of ribociclib and everolimus in children with recurrent or refractory malignant brain tumors: A Pediatric Brain Tumor Consortium study

Journal Article

DeWire, M. D.; Fuller, C.; Campagne, O.; Lin, T.; Pan, H.; Poussaint, T. Y.; Baxter, P. A.; Hwang, E. I.; Bukowinski, A.; Dorris, K.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

Journal Article

Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
Nature Cancer (2021)

Fulltext@MSK | Save

A phase I trial of the CDK 4/6 inhibitor palbociclibin pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)

Journal Article

Van Mater, D.; Gururangan, S.; Becher, O.; Campagne, O.; Leary, S.; Phillips, J. J.; Huang, J.; Lin, T.; Poussaint, T. Y.; Goldman, S.; more...
Pediatric Blood and Cancer (2021)

Fulltext@MSK | Save

Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions

Journal Article

Cobbs, L. V.; Francis, J. H.; Dunkel, I. J.; Gobin, Y. P.; Brodie, S. E.; Abramson, D. H.
Pediatric Blood and Cancer (2021)

Fulltext@MSK | Save